Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.32 |
| ▸ | NAMPT | P43490 | 1/20 | 0.32 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.32 |
| ▸ | STAMBP | O95630 | 1/20 | 0.32 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL9790626 | 0.69 | FDPS (0.51) | — | |
| SCHEMBL9790706 | 0.68 | FDPS (0.50) | — | |
| Phosphonic Acid SCHEMBL9790611 | 0.67 | SCD (0.47) | — | |
| SCHEMBL4722379 | 0.64 | — | — | |
| Phosphonic Acid SCHEMBL9790775 | 0.64 | FDPS (0.54) | — | |
| Phosphonic Acid SCHEMBL9790670 | 0.61 | FDPS (0.54) | — | |
| SCHEMBL31213576 | 0.60 | NUDT1 (0.39) | — | |
| SCHEMBL2712690 | 0.59 | GAA (0.55) | CSNK2A2CSNK2BCSNK2A1CSNK2A3NAMPT | |
| SCHEMBL8124745 | 0.59 | NAMPT (0.60) | CSNK2A2CSNK2BCSNK2A1CSNK2A3LRRK2 | |
| SCHEMBL3070030 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5057505-A | Treatment of illnesses attributed to calcium metabolism disorders | CIBA-GEIGY CORPORATION (US) | 1991-10-15 | — | — | US | disclosed |